GENEDRIVE DIAGNOSTICS LTD

Active Manchester

Research and experimental development on biotechnology

43 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
G

GENEDRIVE DIAGNOSTICS LTD

Research and experimental development on biotechnology

Founded 4 Jan 2000 Active Manchester, United Kingdom 43 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

EPISTEM LIMITED 4 Jan 2000 — 12 Jun 2018
Accounts Submitted 22 Dec 2025 Next due 31 Mar 2027 9 months remaining
Confirmation Submitted 21 Jan 2026 Next due 1 Feb 2027 7 months remaining
Net assets £-22M £5M 2025 year on year
Total assets £3M £4M 2025 year on year
Total Liabilities £24M £1M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Incubator Building Grafton Street Manchester M13 9XX

Telephone

0800 000 0000

Website

www.example.com

Full company profile for GENEDRIVE DIAGNOSTICS LTD (03901952), an active life sciences and medical technology company based in Manchester, United Kingdom. Incorporated 4 Jan 2000. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type full
Next accounts 30 Jun 2026
Due by 31 Mar 2027 9 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

£1.17M

Decreased by £4.01M (-77%)

Net Assets

-£21.58M

Decreased by £5.06M (-31%)

Total Liabilities

£24.39M

Increased by £1.07M (+5%)

Turnover

£954.00k

Increased by £453.00k (+90%)

Employees

43

Debt Ratio

869%

Increased by 526 (+153%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 6,232,492 Shares £6.23m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Mar 20196,232,492£6.23m£1

Officers

Officers

1 active 2 resigned
Status
Russell John ShawDirectorBritishEngland4729 Mar 2022Active

Shareholders

Shareholders (1)

Genedrive Plc
100.0%
51,399

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Genedrive Plc

United Kingdom

Active
Notified 26 Jan 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

GENEDRIVE PLC united kingdom
GENEDRIVE DIAGNOSTICS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Jan 2026Confirmation StatementConfirmation statement made on 18 Jan 2026 with no updates
22 Dec 2025AccountsAnnual accounts made up to 30 Jun 2025
7 Feb 2025AccountsAnnual accounts made up to 30 Jun 2024
21 Jan 2025Confirmation StatementConfirmation statement made on 18 Jan 2025 with no updates
12 Aug 2024OfficersTermination of James Bernard Cheek as director on 6 Aug 2024
21 Jan 2026 Confirmation Statement

Confirmation statement made on 18 Jan 2026 with no updates

22 Dec 2025 Accounts

Annual accounts made up to 30 Jun 2025

7 Feb 2025 Accounts

Annual accounts made up to 30 Jun 2024

21 Jan 2025 Confirmation Statement

Confirmation statement made on 18 Jan 2025 with no updates

12 Aug 2024 Officers

Termination of James Bernard Cheek as director on 6 Aug 2024

Recent Activity

Latest Activity

Confirmation statement made on 18 Jan 2026 with no updates

4 months ago on 21 Jan 2026

Annual accounts made up to 30 Jun 2025

5 months ago on 22 Dec 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 7 Feb 2025

Confirmation statement made on 18 Jan 2025 with no updates

1 years ago on 21 Jan 2025

Termination of James Bernard Cheek as director on 6 Aug 2024

1 years ago on 12 Aug 2024